Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Feldman Maria | VP, Clinical Research | 2 | $0 | $0 | 2017-06-22 |
| Knudson Susan A. | Chief Financial Officer | 8 | $0 | $35.3K | 2017-06-22 |
| Gorbachev Maxim | Director, 10% Owner | 7 | $980.0K | $0 | 2017-06-20 |
| Kamdar Kim P. | Director, 10% Owner | 7 | $0 | $0 | 2017-06-20 |
| Nugent Jeffrey M | Director | 5 | $0 | $0 | 2017-06-20 |
| DEMSKI MARTHA J | Director | 9 | $0 | $0 | 2017-06-20 |
| Locke Kenneth W | Chief Scientific Officer | 7 | $0 | $51.4K | 2016-02-04 |
| Alta Partners VIII, L.P. | Other | 3 | $0 | $1.20M | 2015-12-30 |
| JANNEY DANIEL | Director, 10% Owner | 3 | $0 | $762.1K | 2015-12-15 |
| Mahaffey George W | President and CEO | 2 | $7.8K | $0 | 2015-10-15 |
| ZEINI HANI M | Director | 1 | $0 | $0 | 2015-09-23 |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturing | 11 | $0 | $25.1K | 2015-09-18 |
| KROCHMAL LINCOLN | Chief Medical Officer | 1 | $0 | $0 | 2015-02-10 |
| RusnanoMedInvest LLC | 10% Owner | 3 | $980.0K | $0 | 2014-11-25 |
| DP VII ASSOCIATES LP | 10% Owner | 11 | $0 | $0 | 2014-11-25 |
| SCHOEMAKER KATHLEEN K | 10% Owner | 11 | $0 | $0 | 2014-11-25 |
| NOHRA GUY P | 10% Owner | 19 | $980.0K | $2.09M | 2014-11-25 |
| VITULLO NICOLE | 10% Owner | 12 | $980.0K | $0 | 2014-11-25 |
| BLAIR JAMES C | 10% Owner | 12 | $980.0K | $0 | 2014-11-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Feldman Maria | VP, Clinical Research | A Award deriv | 2017-06-22 | 2017-06-23 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | A Award deriv | 2017-06-22 | 2017-06-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Gorbachev Maxim | Director | A Award deriv | 2017-06-20 | 2017-06-21 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Nugent Jeffrey M | Director | A Award deriv | 2017-06-20 | 2017-06-21 | 12,450 | — | $0 | 12,450 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2017-06-20 | 2017-06-21 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2017-06-20 | 2017-06-22 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Nugent Jeffrey M | Director | A Award deriv | 2017-05-11 | 2017-05-11 | 63,500 | — | $0 | 63,500 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2017-05-11 | 2017-05-11 | 63,500 | — | $0 | 63,500 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2017-05-11 | 2017-05-15 | 63,500 | — | $0 | 63,500 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | A Award deriv | 2017-03-02 | 2017-03-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Feldman Maria | VP Clinical Research & Opera | A Award deriv | 2017-03-02 | 2017-03-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2016-06-21 | 2016-06-23 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2016-06-21 | 2016-06-23 | 16,393 | — | $0 | 16,393 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2016-06-21 | 2016-06-23 | 24,590 | — | $0 | 24,590 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2016-06-21 | 2016-06-23 | 24,590 | — | $0 | 24,590 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2016-06-21 | 2016-06-23 | 16,393 | — | $0 | 16,393 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2016-06-21 | 2016-06-23 | 12,450 | — | $0 | 12,450 | SEC↗ |
| DEMSKI MARTHA J | Director | M Exercise deriv | 2016-06-21 | 2016-06-23 | 16,393 | — | $0 | 0 | SEC↗ |
| Nugent Jeffrey M | Director | A Award deriv | 2016-06-21 | 2016-06-23 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Nugent Jeffrey M | Director | A Award deriv | 2016-06-21 | 2016-06-23 | 24,590 | — | $0 | 24,590 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | A Award deriv | 2016-06-21 | 2016-06-23 | 12,450 | — | $0 | 12,450 | SEC↗ |
| DEMSKI MARTHA J | Director | M Exercise | 2016-06-21 | 2016-06-23 | 16,393 | $1.13 | $18.5K | 16,393 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | A Award deriv | 2016-02-04 | 2016-02-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | A Award deriv | 2016-02-04 | 2016-02-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Alta Partners VIII, L.P. | Other | S Sale | 2015-12-30 | 2015-12-30 | 250,000 | $1.44 | $360.0K | 1,339,776 | SEC↗ |
| Alta Partners VIII, L.P. | Other | S Sale | 2015-12-29 | 2015-12-30 | 493,654 | $1.53 | $755.3K | 1,589,776 | SEC↗ |
| Alta Partners VIII, L.P. | Other | S Sale | 2015-12-28 | 2015-12-30 | 54,333 | $1.59 | $86.4K | 2,083,430 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | S Sale | 2015-12-17 | 2015-12-21 | 1,005 | $1.26 | $1.3K | 0 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | S Sale | 2015-12-17 | 2015-12-21 | 598 | $1.26 | $753 | 0 | SEC↗ |
| JANNEY DANIEL | 10% Owner | S Sale | 2015-12-15 | 2015-12-17 | 529,261 | $1.44 | $762.1K | 2,137,763 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | M Exercise deriv | 2015-11-18 | 2015-11-19 | 4,093 | — | $0 | 23,191 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | M Exercise deriv | 2015-11-18 | 2015-11-19 | 2,005 | — | $0 | 11,366 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | M Exercise | 2015-11-18 | 2015-11-19 | 6,098 | $8.30 | $50.6K | 6,391 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | S Sale | 2015-11-18 | 2015-11-19 | 6,098 | $8.30 | $50.6K | 293 | SEC↗ |
| Mahaffey George W | President and CEO | F Tax w/h | 2015-10-15 | 2015-10-19 | 26,681 | $8.60 | $229.5K | 171,040 | SEC↗ |
| Nugent Jeffrey M | Director | A Award deriv | 2015-09-23 | 2015-09-25 | 10,179 | — | $0 | 10,179 | SEC↗ |
| ZEINI HANI M | Director | A Award deriv | 2015-09-23 | 2015-09-25 | 10,179 | — | $0 | 10,179 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise deriv | 2015-09-18 | 2015-09-22 | 1,000 | — | $0 | 50,182 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | S Sale | 2015-09-18 | 2015-09-22 | 1,000 | $12.20 | $12.2K | 10,848 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise | 2015-09-18 | 2015-09-22 | 1,000 | $1.34 | $1.3K | 11,848 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | M Exercise deriv | 2015-09-01 | 2015-09-03 | 3,000 | — | $0 | 30,718 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | M Exercise | 2015-09-01 | 2015-09-03 | 3,000 | $1.22 | $3.7K | 3,492 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | S Sale | 2015-09-01 | 2015-09-03 | 3,000 | $11.33 | $34.0K | 492 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise deriv | 2015-08-07 | 2015-08-10 | 1,000 | — | $0 | 1,710 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise deriv | 2015-08-07 | 2015-08-17 | 1,000 | — | $0 | 51,182 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise | 2015-08-07 | 2015-08-10 | 1,000 | $1.22 | $1.2K | 11,848 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | S Sale | 2015-08-07 | 2015-08-10 | 1,000 | $12.88 | $12.9K | 10,848 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise | 2015-08-07 | 2015-08-17 | 1,000 | $1.34 | $1.3K | 11,848 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-17 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-17 | 23,940 | — | $0 | 23,940 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2015-06-16 | 2015-06-17 | 12,450 | — | $0 | 12,450 | SEC↗ |
| DEMSKI MARTHA J | Director | A Award deriv | 2015-06-16 | 2015-06-17 | 9,722 | — | $0 | 9,722 | SEC↗ |
| JANNEY DANIEL | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-17 | 12,450 | — | $0 | 12,450 | SEC↗ |
| JANNEY DANIEL | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-17 | 23,940 | — | $0 | 23,940 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-18 | 12,450 | — | $0 | 12,450 | SEC↗ |
| Kamdar Kim P. | Director, 10% Owner | A Award deriv | 2015-06-16 | 2015-06-18 | 23,940 | — | $0 | 23,940 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise deriv | 2015-06-12 | 2015-06-16 | 10,848 | — | $0 | 0 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | M Exercise | 2015-06-12 | 2015-06-16 | 10,848 | $1.22 | $13.2K | 10,848 | SEC↗ |
| Mahaffey George W | President and CEO | P Buy | 2015-03-19 | 2015-03-20 | 1,000 | $7.76 | $7.8K | 197,721 | SEC↗ |
| Kemmerer Christopher | VP, Pharma Dev & Manufacturi | A Award deriv | 2015-02-10 | 2015-02-12 | 42,350 | — | $0 | 42,350 | SEC↗ |
| Knudson Susan A. | Chief Financial Officer | A Award deriv | 2015-02-10 | 2015-02-12 | 45,607 | — | $0 | 45,607 | SEC↗ |
| KROCHMAL LINCOLN | Chief Medical Officer | A Award deriv | 2015-02-10 | 2015-02-12 | 16,288 | — | $0 | 16,288 | SEC↗ |
| Locke Kenneth W | Chief Scientific Officer | A Award deriv | 2015-02-10 | 2015-02-12 | 16,288 | — | $0 | 16,288 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 750,000 | — | $0 | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 6,216,215 | — | $0 | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 2,201,220 | — | $0 | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 4,489,065 | — | $0 | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise deriv | 2014-11-25 | 2014-11-25 | 707,142 | $1.40 | $990.0K | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise deriv | 2014-11-25 | 2014-11-25 | 432,432 | $1.85 | $800.0K | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise deriv | 2014-11-25 | 2014-11-25 | 214,285 | $1.40 | $300.0K | 0 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 9,244,852 | — | $0 | 0 | SEC↗ |
| RusnanoMedInvest LLC | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-25 | 9,244,852 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 2,164,305 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 6,111,968 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 737,422 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 7,252,144 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-11-26 | 92,105 | — | $0 | 0 | SEC↗ |
| BLAIR JAMES C | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-11-26 | 165,790 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-11-26 | 2,827 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 12,578 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 104,247 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 36,913 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-11-26 | 102,282 | — | $0 | 0 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-11-26 | 1,570 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 7,252,144 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 2,164,305 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 6,111,968 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 737,422 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-12-10 | 165,790 | — | $0 | 0 | SEC↗ |
| VITULLO NICOLE | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-12-10 | 92,105 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-12-10 | 1,570 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | M Exercise deriv | 2014-11-25 | 2014-12-10 | 2,827 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 102,282 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 36,913 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 104,247 | — | $0 | 0 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | C Conversion deriv | 2014-11-25 | 2014-12-10 | 12,578 | — | $0 | 0 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 1,161,939 | — | $0 | 1,288,824 | SEC↗ |
| NOHRA GUY P | 10% Owner | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 2,667,024 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 476,845 | — | $0 | 1,765,669 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 735,912 | — | $0 | 2,501,581 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise | 2014-11-25 | 2014-11-25 | 93,676 | $11.29 | $1.06M | 2,595,257 | SEC↗ |
| NOHRA GUY P | 10% Owner | S Sale | 2014-11-25 | 2014-11-25 | 57,143 | $14.00 | $800.0K | 2,538,114 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise | 2014-11-25 | 2014-11-25 | 115,925 | $8.54 | $990.0K | 2,654,039 | SEC↗ |
| NOHRA GUY P | 10% Owner | S Sale | 2014-11-25 | 2014-11-25 | 70,714 | $14.00 | $990.0K | 2,583,325 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise | 2014-11-25 | 2014-11-25 | 35,128 | $8.54 | $300.0K | 2,618,453 | SEC↗ |
| NOHRA GUY P | 10% Owner | S Sale | 2014-11-25 | 2014-11-25 | 21,429 | $14.00 | $300.0K | 2,597,024 | SEC↗ |
| NOHRA GUY P | 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 122,951 | — | $0 | 126,885 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 1,515,549 | — | $0 | 1,515,549 | SEC↗ |
| Gorbachev Maxim | Director, 10% Owner | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 1,585,549 | SEC↗ |
| RusnanoMedInvest LLC | 10% Owner | C Conversion | 2014-11-25 | 2014-11-25 | 1,515,549 | — | $0 | 1,515,549 | SEC↗ |
| RusnanoMedInvest LLC | 10% Owner | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 1,585,549 | SEC↗ |
| BLAIR JAMES C | 10% Owner | M Exercise | 2014-11-25 | 2014-11-26 | 165,790 | $8.54 | $1.42M | 3,122,774 | SEC↗ |
| BLAIR JAMES C | 10% Owner | C Conversion | 2014-11-25 | 2014-11-26 | 2,921,064 | — | $0 | 2,921,064 | SEC↗ |
| BLAIR JAMES C | 10% Owner | M Exercise | 2014-11-25 | 2014-11-26 | 92,105 | $8.54 | $786.6K | 3,013,169 | SEC↗ |
| BLAIR JAMES C | 10% Owner | P Buy | 2014-11-25 | 2014-11-26 | 70,000 | $14.00 | $980.0K | 3,091,642 | SEC↗ |
| BLAIR JAMES C | 10% Owner | F Tax w/h | 2014-11-25 | 2014-11-26 | 101,132 | $14.00 | $1.42M | 3,021,642 | SEC↗ |
| BLAIR JAMES C | 10% Owner | F Tax w/h | 2014-11-25 | 2014-11-26 | 56,185 | $14.00 | $786.6K | 2,956,984 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | C Conversion | 2014-11-25 | 2014-11-26 | 46,309 | — | $0 | 46,309 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | F Tax w/h | 2014-11-25 | 2014-11-26 | 958 | $14.00 | $13.4K | 46,921 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | M Exercise | 2014-11-25 | 2014-11-26 | 2,827 | $8.54 | $24.1K | 49,748 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | F Tax w/h | 2014-11-25 | 2014-11-26 | 1,725 | $14.00 | $24.1K | 48,023 | SEC↗ |
| SCHOEMAKER KATHLEEN K | 10% Owner | M Exercise | 2014-11-25 | 2014-11-26 | 1,570 | $8.54 | $13.4K | 47,879 | SEC↗ |
| NOHRA GUY P | 10% Owner | X Exercise | 2014-11-25 | 2014-12-01 | 93,676 | $8.54 | $800.0K | 2,595,257 | SEC↗ |
| VITULLO NICOLE | 10% Owner | F Tax w/h | 2014-11-25 | 2014-12-10 | 56,185 | $14.00 | $786.6K | 2,956,985 | SEC↗ |
| VITULLO NICOLE | 10% Owner | M Exercise | 2014-11-25 | 2014-12-10 | 165,790 | $8.54 | $1.42M | 3,122,775 | SEC↗ |
| VITULLO NICOLE | 10% Owner | F Tax w/h | 2014-11-25 | 2014-12-10 | 101,132 | $14.00 | $1.42M | 3,021,643 | SEC↗ |
| VITULLO NICOLE | 10% Owner | P Buy | 2014-11-25 | 2014-12-10 | 70,000 | $14.00 | $980.0K | 3,091,643 | SEC↗ |
| VITULLO NICOLE | 10% Owner | C Conversion | 2014-11-25 | 2014-12-10 | 2,921,065 | — | $0 | 2,921,065 | SEC↗ |
| VITULLO NICOLE | 10% Owner | M Exercise | 2014-11-25 | 2014-12-10 | 92,105 | $8.54 | $786.6K | 3,013,170 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | F Tax w/h | 2014-11-25 | 2014-12-10 | 958 | $14.00 | $13.4K | 46,923 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | C Conversion | 2014-11-25 | 2014-12-10 | 46,311 | — | $0 | 46,311 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | F Tax w/h | 2014-11-25 | 2014-12-10 | 1,725 | $14.00 | $24.1K | 48,025 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | M Exercise | 2014-11-25 | 2014-12-10 | 2,827 | $8.54 | $24.1K | 49,750 | SEC↗ |
| DP VII ASSOCIATES LP | 10% Owner | M Exercise | 2014-11-25 | 2014-12-10 | 1,570 | $8.54 | $13.4K | 47,881 | SEC↗ |